A drug currently used to treat cancer patients has been found to sharpen memory in experiments involving rats. RGFP966, an HDAC inhibitor, holds potential as treatment for Alzheimer's disease.
A drug currently used to treat cancer patients has been found to sharpen memory in experiments involving rats. RGFP966, an HDAC inhibitor, holds potential as treatment for Alzheimer's disease.
Share this Article
Recommended